Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, et al.
The Journal of Clinical Endocrinology & Metabolism (2014) Vol. 99, Iss. 5, pp. E754-E765
Open Access | Times Cited: 510

Showing 1-25 of 510 citing articles:

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen, Erik K. Alexander, Keith C. Bible, et al.
Thyroid (2015) Vol. 26, Iss. 1, pp. 1-133
Open Access | Times Cited: 14563
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir, Ryma Benayed, Ronak Shah, et al.
Nature Medicine (2017) Vol. 23, Iss. 6, pp. 703-713
Open Access | Times Cited: 2983
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal, Rehan Akbani, Bülent Arman Aksoy, et al.
Cell (2014) Vol. 159, Iss. 3, pp. 676-690
Open Access | Times Cited: 2693
Thyroid cancer
Maria E. Cabanillas, David G. McFadden, Cosimo Durante
The Lancet (2016) Vol. 388, Iss. 10061, pp. 2783-2795
Open Access | Times Cited: 1236
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
Hossein Gharib, Enrico Papini, Jeffrey R. Garber, et al.
Endocrine Practice (2016) Vol. 22, pp. 1-60
Open Access | Times Cited: 1128
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 3, pp. 1052-1066
Open Access | Times Cited: 1061
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Zubair Baloch, L. Sylvia, Justine A. Barletta, et al.
Endocrine Pathology (2022) Vol. 33, Iss. 1, pp. 27-63
Closed Access | Times Cited: 722
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay
Yuri E. Nikiforov, Sally E. Carty, Simion I. Chiosea, et al.
Cancer (2014) Vol. 120, Iss. 23, pp. 3627-3634
Open Access | Times Cited: 480
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Eleonora Molinaro, Cristina Romei, Agnese Biagini, et al.
Nature Reviews Endocrinology (2017) Vol. 13, Iss. 11, pp. 644-660
Closed Access | Times Cited: 399
TERT promoter mutations in thyroid cancer
Rengyun Liu, Mingzhao Xing
Endocrine Related Cancer (2016) Vol. 23, Iss. 3, pp. R143-R155
Open Access | Times Cited: 365
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas, Mabel Ryder, Camilo Jiménez
Endocrine Reviews (2019) Vol. 40, Iss. 6, pp. 1573-1604
Open Access | Times Cited: 268
Understanding TERT Promoter Mutations: A Common Path to Immortality
Robert J.A. Bell, H. Tomas Rube, Ana Xavier‐Magalhães, et al.
Molecular Cancer Research (2016) Vol. 14, Iss. 4, pp. 315-323
Open Access | Times Cited: 261
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer
Rengyun Liu, Justin A. Bishop, Guangwu Zhu, et al.
JAMA Oncology (2016) Vol. 3, Iss. 2, pp. 202-202
Closed Access | Times Cited: 244
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola, Rossella Elisei, Dagmar Führer, et al.
European Thyroid Journal (2019) Vol. 8, Iss. 5, pp. 227-245
Open Access | Times Cited: 240
TERT promoter mutations in telomere biology
Barbara Heidenreich, Rajiv Kumar
Mutation Research/Reviews in Mutation Research (2016) Vol. 771, pp. 15-31
Closed Access | Times Cited: 185
Role of Molecular Markers in Thyroid Nodule Management: Then and Now
Yuri E. Nikiforov
Endocrine Practice (2017) Vol. 23, Iss. 8, pp. 979-989
Closed Access | Times Cited: 173
Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules
Masha J. Livhits, Catherine Zhu, Eric J. Kuo, et al.
JAMA Oncology (2020) Vol. 7, Iss. 1, pp. 70-70
Open Access | Times Cited: 139
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
David C. Shonka, Alan L. Ho, Ashish V. Chintakuntlawar, et al.
Head & Neck (2022) Vol. 44, Iss. 6, pp. 1277-1300
Open Access | Times Cited: 72
Genomic alterations in thyroid cancer: biological and clinical insights
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
Giorgio Grani, Livia Lamartina, Cosimo Durante, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 6, Iss. 6, pp. 500-514
Closed Access | Times Cited: 166
Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients
Young Shin Song, Jung‐Ah Lim, Hoon Choi, et al.
Cancer (2016) Vol. 122, Iss. 9, pp. 1370-1379
Open Access | Times Cited: 160
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma
Bin Xu, Ronald Ghossein
Endocrine Pathology (2016) Vol. 27, Iss. 3, pp. 205-212
Closed Access | Times Cited: 158
European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium
Markus Luster, Cumali Aktolun, Isabel Amendoeira, et al.
Thyroid (2018) Vol. 29, Iss. 1, pp. 7-26
Closed Access | Times Cited: 156
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics
Ralf Paschke, Silvia Cantara, Anna Crescenzi, et al.
European Thyroid Journal (2017) Vol. 6, Iss. 3, pp. 115-129
Open Access | Times Cited: 145
Page 1 - Next Page

Scroll to top